Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Steven E. Kempers"'
Autor:
Linda Stein Gold, Javier Alonso-Llamazares, Zoe D. Draelos, Melinda J. Gooderham, Steven E. Kempers, Leon H. Kircik, Mark G. Lebwohl, Kim A. Papp, David M. Pariser, Darryl P. Toth, Gil Yosipovitch, Robert C. Higham, Amy Feng, David R. Berk
Publikováno v:
American Journal of Clinical Dermatology. 24:305-313
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b65648ce45871b894bc0e0c6516e906c
https://doi.org/10.1007/s40257-022-00739-3
https://doi.org/10.1007/s40257-022-00739-3
Autor:
Matthew J. Zirwas, Zoe D. Draelos, Janet DuBois, Leon H. Kircik, Angela Y. Moore, Linda Stein Gold, Javier Alonso-Llamazares, Michael Bukhalo, Suzanne Bruce, Kimmie Eads, Lawrence J. Green, Scott T. Guenthner, Laura K. Ferris, Seth B. Forman, Steven E. Kempers, Edward Lain, Charles W. Lynde, David M. Pariser, Darryl P. Toth, Paul S. Yamauchi, Robert C. Higham, David Krupa, Patrick Burnett, David R. Berk
Publikováno v:
JAMA Dermatology.
ImportanceCurrent topical treatment options for seborrheic dermatitis are limited by efficacy and/or safety.ObjectiveTo assess safety and efficacy of roflumilast foam, 0.3%, in adult patients with seborrheic dermatitis affecting the scalp, face, and/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca1dec1f89c02bd2aeda1f7193cbee56
https://doi.org/10.1001/jamadermatol.2023.0846
https://doi.org/10.1001/jamadermatol.2023.0846
Autor:
Linda, Stein Gold, Javier, Alonso-Llamazares, Zoe D, Draelos, Melinda J, Gooderham, Steven E, Kempers, Leon H, Kircik, Mark G, Lebwohl, Kim A, Papp, David M, Pariser, Darryl P, Toth, Gil, Yosipovitch, Robert C, Higham, Amy, Feng, David R, Berk
Publikováno v:
American journal of clinical dermatology.
Itch is the most bothersome symptom reported by patients with psoriasis. Safe and effective treatments for psoriasis that also address itch are needed.To report effects of roflumilast cream on itch-related outcomes from a Phase 2b trial.Adults with c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cb15f4a27ae069bab44f2382c3c9ce4c
https://pubmed.ncbi.nlm.nih.gov/36370336
https://pubmed.ncbi.nlm.nih.gov/36370336
Autor:
Mark G, Lebwohl, Kim A, Papp, Linda, Stein Gold, Melinda J, Gooderham, Leon H, Kircik, Zoe D, Draelos, Steven E, Kempers, Mathew, Zirwas, Kathleen, Smith, David W, Osborne, Marie-Louise, Trotman, Lynn, Navale, Charlotte, Merritt, David R, Berk, Howard, Welgus, Matthew James, Zirwas
Publikováno v:
New England Journal of Medicine. 383:229-239
Systemic oral phosphodiesterase type 4 (PDE-4) inhibitors have been effective in the treatment of psoriasis. Roflumilast cream contains a PDE-4 inhibitor that is being investigated for the topical treatment of psoriasis.In this phase 2b, double-blind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c66566e39c2d5cda3b2e8e2226e62e2
https://doi.org/10.1056/nejmoa2000073
https://doi.org/10.1056/nejmoa2000073
Autor:
Mark G, Lebwohl, Leon H, Kircik, Angela Y, Moore, Linda, Stein Gold, Zoe D, Draelos, Melinda J, Gooderham, Kim A, Papp, Jerry, Bagel, Neal, Bhatia, James Q, Del Rosso, Laura K, Ferris, Lawrence J, Green, Adelaide A, Hebert, Terry, Jones, Steven E, Kempers, David M, Pariser, Paul S, Yamauchi, Matthew, Zirwas, Lorne, Albrecht, Alim R, Devani, Mark, Lomaga, Amy, Feng, Scott, Snyder, Patrick, Burnett, Robert C, Higham, David R, Berk
Publikováno v:
JAMA. 328:1073
ImportanceOnce-daily roflumilast cream, 0.3%, a potent phosphodiesterase 4 inhibitor, demonstrated efficacy and was well tolerated in a phase 2b trial of patients with psoriasis.ObjectiveTo evaluate the efficacy of roflumilast cream, 0.3%, applied on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::565d537d0b59fe6b651c8d0f333ec1af
https://doi.org/10.1001/jama.2022.15632
https://doi.org/10.1001/jama.2022.15632
Autor:
B. Elewski, S. Brand, T. Degenhardt, S. Curelop, R. Pollak, R. Schotzinger, A. Tavakkol, Javier Alonso‐Llamazares, Scott J. Ashton, Neal Bhatia, Michael Billings, Andrew Blauvelt, Norman Bystol, Brandt Dodson, Michael H. Gold, Kimberly Grande, Michael Jarratt, Terry S. Jones, Maria A. Kasper, Steven E. Kempers, Brock McConnehey, Michael Noss, David Pariser, Lawrence Parish, Phoebe Rich, Joseph Ahmad Samady, Joel Schlessinger, Doug Schumacher, Kenneth Stein, Cynthia Strout, Eduardo Tschen, John H. Tu, Max Weisfeld
Publikováno v:
The British journal of dermatologyReferences. 184(2)
BACKGROUND Onychomycosis is a fungal disease that affects the fingernails and toenails and is predominantly caused by dermatophytes. VT-1161 is a novel inhibitor of fungal CYP51 through the inhibition of lanosterol demethylase, and has demonstrated p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0225707b52f9abd6cd0998d7c888f102
https://pubmed.ncbi.nlm.nih.gov/32643171
https://pubmed.ncbi.nlm.nih.gov/32643171
Autor:
Angela, Moore, Lawrence J, Green, Suzanne, Bruce, Neil, Sadick, Eduardo, Tschen, Philip, Werschler, Fran E, Cook-Bolden, Sunil S, Dhawan, Douglass, Forsha, Michael H, Gold, Scott, Guenthner, Steven E, Kempers, Leon H, Kircik, Jennifer L, Parish, Marta I, Rendon, Phoebe, Rich, Linda, Stein-Gold, Stephen K, Tyring, Robert A, Weiss, Adnan, Nasir, Carsten, Schmitz, Terry I, Boodhoo, Alexandre, Kaoukhov, David R, Berk
Publikováno v:
Journal of drugs in dermatology : JDD. 17(9)
Side effects may limit the use of current tetracycline-class antibiotics for acne.Evaluate the efficacy and safety of once-daily sarecycline, a novel, narrow-spectrum tetracycline-class antibiotic, in moderate to severe acne.Patients 9-45 years with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d82139215e9f4f5d26f769f5bf923cae
https://pubmed.ncbi.nlm.nih.gov/30235387
https://pubmed.ncbi.nlm.nih.gov/30235387
Autor:
Zoe Diana, Draelos, David A, Rodriguez, Steven E, Kempers, Suzanne, Bruce, Marina I, Peredo, Jeanine, Downie, Joan-En, Chang-Lin, David R, Berk, Shiling, Ruan, Alexandre, Kaoukhov
Publikováno v:
Journal of drugs in dermatology : JDD. 16(6)
pBACKGROUND: Acne vulgaris has varying physical and psychological effects in men and women of different ages, races, and ethnicities./ppOBJECTIVE: This analysis assessed the relationship of age, sex, and race to treatment response with once-daily top
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5469ebf879703fcee7d75bb3a663d233
https://pubmed.ncbi.nlm.nih.gov/28686777
https://pubmed.ncbi.nlm.nih.gov/28686777
Autor:
Zoe D Draelos, Steven E Kempers, Stacy R Smith, David C Wilson, Christopher V Powala, Mark Bradshaw, Esther Estes, Stuart D Shanler
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 2:S49
not available. Disclosure: Study sponsored by Alcaris.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::952ed6e95316543febdbab963af82d1f
https://doi.org/10.25251/skin.2.supp.49
https://doi.org/10.25251/skin.2.supp.49
Autor:
Raza, Aly, H Irving, Katz, Steven E, Kempers, Donald P, Lookingbill, Nicholas, Lowe, Alan, Menter, Manuel, Morman, Ronald C, Savin, Mitchell, Wortzman
Publikováno v:
International journal of dermatology. 42
Seborrheic dermatitis is a common inflammatory skin disorder that usually occurs in patients with pre-existing seborrhea. The etiology of seborrheic dermatitis is uncertain. Typically, sites dense with sebaceous glands support growth of the lipophili
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9de28813057a618387f9e8eca8ad91d1
https://pubmed.ncbi.nlm.nih.gov/12895183
https://pubmed.ncbi.nlm.nih.gov/12895183